Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

GLPGGLPG
17 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in LAKEFRONT BIOTHERAPEUTICS NV

Yes. Goldman Sachs holds 56,581 shares of GLPG (Lakefront Biotherapeutics), worth $1.7M, as of its Q2 2026 13F filing. It increased the position by 11,210 shares (+24.7%) from Q1 2026. Goldman Sachs has held GLPG since Q2 2025, across 5 quarterly 13F filings.

Current Value

$1.7M

Current Shares

56,581

Total Value Change

+$589,298

Total Shares Change

+36,748

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
56,581
+24.7%
$1.7M0.0%$27.73
31
2026-Q1
Increased
45,371
+307.1%
$1.4M0.0%$33.05
41
2025-Q4
Decreased
11,144
-83.2%
$364,4090.0%$32.61
0
2025-Q3
Increased
66,141
+16.6%
$2.3M0.0%$34.43
30
2025-Q2
New
56,731
-
$1.6M0.0%$27.98
35
2025-Q1
Exited
0
-100.0%
$00.0%$25.46
0
2024-Q4
Decreased
24,731
-52.5%
$680,1030.0%$27.30
0
2024-Q3
Decreased
52,018
-34.8%
$1.5M0.0%$29.28
0
2024-Q2
Decreased
79,835
-12.7%
$2M0.0%$24.78
0
2024-Q1
Decreased
91,485
-23.2%
$2.9M0.0%$32.20
0
2023-Q4
Increased
119,085
+58.4%
$4.8M0.0%$40.65
38
2023-Q3
Increased
75,167
+186.8%
$2.6M0.0%$34.55
42
2023-Q2
Decreased
26,209
-38.3%
$1.1M0.0%$40.38
0
2023-Q1
Decreased
42,445
-33.2%
$1.6M0.0%$37.53
0
2022-Q4
Increased
63,569
+45.1%
$2.8M0.0%$44.38
36
2022-Q3
Increased
43,803
+120.9%
$1.9M0.0%—
42
2022-Q2
First report
19,833
-
$1.1M0.0%—
0

Other major holders of GLPG: SANDS CAPITAL MANAGEMENT, LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used